Natco Pharma Limited — Others, 07-01-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

NATCO Pharma Limited has provided a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations for the quarter ended December 31, 2024. This certification confirms that securities received for dematerialization have been appropriately canceled and the depositories' records have been updated within the stipulated timeframe.

This update reinforces the firm's commitment to maintaining accurate securities management, which could enhance investor confidence in the company's operational integrity. As the company continues to streamline its processes, this may present a positive outlook for stakeholders, emphasizing efficient governance and transparency in transactions.